Literature DB >> 18559955

Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study.

Pierrick Bedouch1, Bruno Charpiat, Ornella Conort, François-Xavier Rose, Laurence Escofier, Michel Juste, Renaud Roubille, Benoît Allenet.   

Abstract

BACKGROUND: The development of clinical pharmacy activities in most European countries is underway; however, data on these activities are still poorly reported. Multicenter studies are necessary to standardize and demonstrate the value of clinical pharmacy activities in these countries.
OBJECTIVE: To document clinical pharmacists' daily routine interventions (PIs) to identify trends of intervention, drugs, and situations most frequently associated with drug-related problems (DRPs) and to estimate physicians' acceptance of PI.
METHODS: A prospective study of PIs was conducted in 6 French hospitals. The sample consisted of 300 randomized PIs per hospital, recorded during the medication order validation process when a DRP was identified. We recorded patients' demographic characteristics, drugs involved, wards, DRP description, pharmacists' recommendations, and whether or not the recommendations were accepted by the physicians.
RESULTS: A total of 38,626 medication orders were analyzed by 28 clinical pharmacists, leading to 1800 PIs (4.66 PIs per 100 medication orders). Of the 1800 PIs, 25.9% targeted psychotropic drugs, 15.9% targeted antithrombotic drugs, 15.5% targeted digestive and metabolic drugs, and 15.0% targeted cardiovascular drugs. The most commonly identified DRPs were nonconformity to guidelines or contraindication (21.3%), followed by improper administration (20.6%), supratherapeutic dose (19.2%), and drug interaction (12.6%). Nearly half (42.2%) of the pharmacists' recommendations were related to drug choice (drug switch 22.2%, drug discontinuation 16.3%, addition of a new drug 3.7%) followed by dose adjustment (23.8%), optimization of administration (21.9%; change of administration route 10.3%, administration modalities 11.6%), and need for drug monitoring (12.2%). The rate of physicians' acceptance was 73.4% (15.3% refusals, 11.3% not assessable).
CONCLUSIONS: In French hospitals, pharmacists contribute to preventing DRPs during medication order validation. This study suggests that a few types of drugs and errors constitute a substantial proportion of PIs. Knowledge of the most frequent DRPs could significantly increase the efficiency of clinical PIs.

Entities:  

Mesh:

Year:  2008        PMID: 18559955     DOI: 10.1345/aph.1L045

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  17 in total

1.  Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospital.

Authors:  Derar H Abdel-Qader; Lindsay Harper; Judith A Cantrill; Mary P Tully
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Physicians' perception of CPOE implementation.

Authors:  Benoît Allenet; Pierrick Bedouch; Stéphanie Bourget; Magalie Baudrant; Luc Foroni; Jean Calop; Jean-Luc Bosson
Journal:  Int J Clin Pharm       Date:  2011-05-13

3.  Pharmacists' interventions on intravenous to oral conversion for potassium.

Authors:  B Charpiat; P Bedouch; O Conort; M Juste; F X Rose; R Roubille; B Allenet
Journal:  Int J Clin Pharm       Date:  2014-03-15

Review 4.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

5.  Development of a pharmacist collaborative care program for pulmonary arterial hypertension.

Authors:  Pierrick Bedouch; Matthieu Roustit; Sébastien Quetant; Claire Chapuis; Magalie Baudrant-Boga; Audrey Lehmann; Christel Saint-Raymond; Christophe Pison; Benoit Allenet
Journal:  Int J Clin Pharm       Date:  2011-12

6.  Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.

Authors:  Mélina Raimbault-Chupin; Laurence Spiesser-Robelet; Véronique Guir; Cédric Annweiler; Olivier Beauchet; Marie-Anne Clerc; Frédéric Moal
Journal:  Int J Clin Pharm       Date:  2013-07-16

7.  Characteristics of Pharmacists' Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study.

Authors:  A L Yailian; E Huet; B Charpiat; O Conort; M Juste; R Roubille; M Bourdelin; J Gravoulet; C Mongaret; C Vermorel; P Bedouch; A Janoly-Duménil
Journal:  Int J Clin Pract       Date:  2022-06-28       Impact factor: 3.149

8.  Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward.

Authors:  Ghazal Vessal
Journal:  Pharm World Sci       Date:  2009-10-17

9.  Clinical pharmacy services in an Iranian teaching hospital: a descriptive study.

Authors:  Simin Dashti-Khavidaki; Hossein Khalili; Hadi Hamishekar; Sheida Shahverdi
Journal:  Pharm World Sci       Date:  2009-10-06

10.  Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia.

Authors:  Clement Delage; Hélène Lelong; Francoise Brion; Jacques Blacher
Journal:  Eur J Hosp Pharm       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.